Fertility News and Research

RSS

Overview of procedures and techniques used for embryo transfer under transvaginal ultrasound guidance

Fertility and reproductive specialists are invited to join a live, online chat event entitled, “Transvaginal Ultrasound Transfers” at www.CookARTLab.com. The

12 Oct 2009

Women who take fertility drugs are at greater risk to develop thyroid cancer

Women who take the most common fertility drugs, progesterone and clomiphene, are at a greater risk to develop thyroid cancer than those who don't, according to a study by the Institute of Cancer Epidemiology, Danish Cancer Society.

12 Oct 2009

INVO Bioscience announce the birth of the first baby conceived by the INVO procedure and INVOcell device

INVO Bioscience, Inc., a medical device company focused on treatment options for patients diagnosed with infertility, announced that on September 29, 2009 the birth of the first baby conceived by the INVO procedure and INVOcell device. The mother is a 40 year old Pakistan woman who had suffered from infertility for 16 years.

9 Oct 2009

Program on protecting and preserving reproductive health

Octomom ... Kate Gosselin ... the recent embryo mix-up case in Ohio ... all stories stemming from infertility treatments and making national headlines. But, much to the surprise of many, there are several types of infertility that are actually preventable - something starting to make headlines. That's why The American Fertility Association's infertility prevention education outreach program, Manicures & Martinis, continues to sweep the nation with its next stop in Beverly Hills.

9 Oct 2009

DuoFertility helps women to conceive naturally without IVF

One in six women in the UK have difficulties conceiving – a figure which is predicted to rise to one in three by 2020. Many women turn to costly, invasive fertility treatments such as IVF, which typically has a success rate of 20%. DuoFertility is a groundbreaking new fertility monitor which helps women to maximise their chances of conceiving naturally without resorting to fertility treatment.

9 Oct 2009

Medical tourism in Latin America requires regulation: University of Montreal researchers

Medical tourism in Latin America needs to be regulated to protect consumers, according to Universit- de Montr-al researchers. A new study published in the journal Developing World Bioethics argues that Argentinean fertility clinics are increasingly marketing themselves to international health care consumers: these clinics offer all-inclusive packages with fixed prices that feature airfare, accommodations, transfers, language interpreters and, of course, fertility treatments.

8 Oct 2009

Birth control pills may have an impact on choice of partners

There is no doubt that modern contraception has enabled women to have unprecedented control over their own fertility. However, is it possible that the use of oral contraceptives is interfering with a woman's ability to choose, compete for and retain her preferred mate?

8 Oct 2009

Vitrolife and Cellartis extend collaboration in stem cell research

Vitrolife has entered into a new 3-year collaboration agreement with Cellartis AB regarding the development of new products for the culture, handling and differentiation of stem cells. The agreement extends the previous collaboration between the companies.

8 Oct 2009

The Top 10 Medical Innovations for 2010 announced at Cleveland Clinic Medical Innovation Summit

Cleveland Clinic's Top 10 Medical Innovations for 2010 list features a wide range of new techniques and therapies that are being developed to treat everything from deafness and Parkinson's disease to pneumonia and sleep disorders.

7 Oct 2009

Vitro Diagnostics' research reveals expanded uses of its fluorescent stem cells

Vitro Diagnostics, Inc., dba Vitro Biopharma, announced completion of a research report concerning its fluorescent stem cells, http://www.vitrobiopharma.com/wp-content/uploads/2009/10/fluorescent-msc-10-3.pdf. This report revealed transfer of fluorescent to differentiated cells including chondrocytes, cells responsible for making cartilage.

7 Oct 2009

Repros announces results of its Androxal efficacy study for secondary hypogonadism

Repros Therapeutics Inc. today announced results from an exploratory, efficacy and safety study of its oral investigational product, enclomiphene citrate (Androxal®), in men with secondary hypogonadism who were receiving testosterone replacement treatment. Secondary hypogonadism is a deficiency state in which the male hormone testosterone goes below the normal range, even in aging men, due to inadequate stimulation of the testes by the pituitary.

7 Oct 2009

Few risks to babies born to parents who underwent cancer treatment in childhood: Study

Whether they can have children is one of the major concerns for adult survivors of childhood and adolescent cancer because fertility can be compromised by cancer treatment. For cancer survivors who can have children, two new studies led by researchers at Fred Hutchinson Cancer Research Center may help alleviate fears that their childhood disease will adversely impact their newborns.

3 Oct 2009

Role of gene that could influence fertility identified in mice

Virginia Commonwealth University researchers have identified the role of a gene in regulating molecular signals involved with ovarian follicle development, which may one day help shed light on some of the causes of fertility issues in humans.

3 Oct 2009

Brdt protein in developing sperm cells direct tight re-packaging of sperm DNA

In the quest for speed, olympic swimmers shave themselves or squeeze into high-tech super-suits. In the body, sperm are the only cells that swim and, as speed is crucial to fertility, have developed their own ways to become exceptionally streamlined. Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg and Grenoble, the Institut de Biologie Structurale (IBS) and the Institut Albert Bonniot, both also in Grenoble, have been studying the secrets of speedy sperm.

1 Oct 2009

Incept BioSystems commences human clinical trial of its SMART Embryo Culture System

Incept BioSystems, Inc., a privately-held biomedical device company using patented microfluidic technology developed at the University of Michigan, announced today that it has initiated the first U.S. human clinical trial of its proprietary SMART Embryo Culture System. The microscale SMART technology platform is designed to improve the in vitro manipulation, performance, and viability of embryos for the treatment of patients undergoing in vitro fertilization (IVF).

1 Oct 2009

Swemed Sense oocyte aspiration needle available now for Australian customers

“Swemed Sense, with its unique characteristics, is an important part of our existing product portfolio in Europe, and is now available even to our Australian customers, Says Vitrolife's Vice President of Marketing and Sales, Nils Sellbom. Vitrolife have identified Australia as one of the key markets in the world and we have a office located in Melbourne. Approximately 67 000 fertility treatment cycles are conducted in Australia and New Zealand each year”

1 Oct 2009

Safety profiles of JANUVIA and JANUMET drugs established through clinical development program

Merck has thoroughly reviewed the safety data for sitagliptin, and sitagliptin was not associated with an increase in the incidence of pancreatitis in preclinical studies or in clinical trials of up to two years in duration with more than 6,000 patients.

28 Sep 2009

European CHMP recommends Merck's JANUVIA and JANUMET as add-on to insulin

Merck & Co., Inc., which operates in many countries as Merck Sharp & Dohme (MSD), has received a positive opinion from the European Medicines Agency’s (EMEA) Committee for Medicinal Products for Human Use (CHMP) for JANUVIA® tablets and JANUMET® tablets recommending their use as add-on to insulin for the treatment of type 2 diabetes.

26 Sep 2009

AFA reacts to an Ohio woman's claims of an embroyo mix up

An Ohio woman, 40-year-old Carolyn Savage, claims a fertility clinic implanted the wrong embryo and that the baby she's due to deliver the first week in October is not hers. Several media reports state Savage and her husband plan to give the baby boy to his biological parents. The name of the clinic is not being released in this very rare alleged case.

24 Sep 2009

Merck, QIAGEN to collaborate to increase access to HPV vaccination and HPV DNA testing in developing countries

Merck & Co., Inc. and QIAGEN N.V. today announced their intent to collaborate on a new program to increase access to HPV vaccination and HPV DNA testing in some of the most resource-poor areas of the world.

From QIAGEN Manchester Limited 24 Sep 2009

Fertility News and Research

Overview of procedures and techniques used for embryo transfer under transvaginal ultrasound guidance

Women who take fertility drugs are at greater risk to develop thyroid cancer

INVO Bioscience announce the birth of the first baby conceived by the INVO procedure and INVOcell device

Program on protecting and preserving reproductive health

DuoFertility helps women to conceive naturally without IVF

Medical tourism in Latin America requires regulation: University of Montreal researchers

Birth control pills may have an impact on choice of partners

Vitrolife and Cellartis extend collaboration in stem cell research

The Top 10 Medical Innovations for 2010 announced at Cleveland Clinic Medical Innovation Summit

Vitro Diagnostics' research reveals expanded uses of its fluorescent stem cells

Repros announces results of its Androxal efficacy study for secondary hypogonadism

Few risks to babies born to parents who underwent cancer treatment in childhood: Study

Role of gene that could influence fertility identified in mice

Brdt protein in developing sperm cells direct tight re-packaging of sperm DNA

Incept BioSystems commences human clinical trial of its SMART Embryo Culture System

Swemed Sense oocyte aspiration needle available now for Australian customers

Safety profiles of JANUVIA and JANUMET drugs established through clinical development program

European CHMP recommends Merck's JANUVIA and JANUMET as add-on to insulin

AFA reacts to an Ohio woman's claims of an embroyo mix up

Merck, QIAGEN to collaborate to increase access to HPV vaccination and HPV DNA testing in developing countries

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News